Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 1
2016 2
2019 3
2020 4
2021 10
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O, Chantaravisoot N, Wongkongkathep P, Kungsukool S, Chetprayoon P, Chanvorachote P, Vinayanuwattikun C, Pongrakhananon V. Wattanathamsan O, et al. Among authors: vinayanuwattikun c. J Biomed Sci. 2023 Jan 13;30(1):4. doi: 10.1186/s12929-023-00898-3. J Biomed Sci. 2023. PMID: 36639650 Free PMC article.
Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma.
Pakvisal N, Chantranuwat P, Vinayanuwattikun C, Sitthideatphaiboon P, Teerapakpinyo C, Shuangshoti S, Benjacholamas V, Pornpattanarak N, Sriuranpong V. Pakvisal N, et al. Among authors: vinayanuwattikun c. Transl Cancer Res. 2022 Jul;11(7):2238-2248. doi: 10.21037/tcr-21-2633. Transl Cancer Res. 2022. PMID: 35966323 Free PMC article.
Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patients.
Pakvisal N, Kongkavitoon P, Sathitruangsak C, Pornpattanarak N, Boonsirikamchai P, Ouwongprayoon P, Aporntewan C, Chantranuwatana P, Mutirangura A, Vinayanuwattikun C. Pakvisal N, et al. Among authors: vinayanuwattikun c. Sci Rep. 2022 Nov 2;12(1):18439. doi: 10.1038/s41598-022-21891-0. Sci Rep. 2022. PMID: 36323738 Free PMC article.
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P, Teerapakpinyo C, Korphaisarn K, Leelayuwatanakul N, Pornpatrananrak N, Poungvarin N, Chantranuwat P, Shuangshoti S, Aporntewan C, Chintanapakdee W, Sriuranpong V, Vinayanuwattikun C. Sitthideatphaiboon P, et al. Among authors: vinayanuwattikun c. Sci Rep. 2022 Feb 9;12(1):2167. doi: 10.1038/s41598-022-06239-y. Sci Rep. 2022. PMID: 35140316 Free PMC article.
Candidate cancer-targeting agents identified by expression-profiling arrays.
Termglinchan V, Wanichnopparat W, Suwanwongse K, Teeyapant C, Chatpermporn K, Leerunyakul K, Chuadpia K, Sirimaneethum O, Wijitworawong P, Mutirangura W, Aporntewan C, Vinayanuwattikun C, Mutirangura A. Termglinchan V, et al. Among authors: vinayanuwattikun c. Onco Targets Ther. 2013 Apr 23;6:447-58. doi: 10.2147/OTT.S42858. Print 2013. Onco Targets Ther. 2013. PMID: 23637543 Free PMC article.
31 results